Back to search
Still's Disease, Adult-Onset
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Still's Disease, Adult-Onset trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Still's Disease, Adult-Onset trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Background: Inflammatory conditions can cause symptoms like fevers, arthritis, and rash. Systemic juvenile idiopathic arthritis (sJIA) is one of these conditio…
The study is a phase II trial designed to evaluate the clinical efficacy, safety, and tolerability of MAS825 (arumakimig) in pediatric and adult participants wi…
This study aims to assess and characterize the treatment patterns, and long-term clinical outcomes and demographic characteristics of patients diagnosed with Fa…
The purpose of this study is to compare the efficacy and safety of firsekibart versus anakinra in patients with AOSD.
To facilitate clinical, basic science, and translational research projects involving the study of rheumatic diseases.
Adult Onset Still Disease (AOSD) and Systemic onset Juvenile Idiopathic Arthritis (SoJIA) are two rare multifactorial diseases associated with systemic inflamma…
The purpose of this study is to evaluate the efficacy and safety of anakinra in Chinese patients with Systemic Juvenile Idiopathic Arthritis (SJIA) and Adult-On…
This study was designed to evaluate the efficacy and safety of canakinumab administered subcutaneously every 4 weeks for at least 48 weeks in Japanese patients…